comparemela.com

Latest Breaking News On - Xar incorporated - Page 1 : comparemela.com

Generative AI in Pharma Market to Exceed USD 2,258 1 Mn by 2033, with 31 2% CAGR | Marketresearch bi

Marketresearch.biz reports that the Generative AI in Pharma market size is expected to be worth around USD 2258.1 Mn by 2033 from USD 159.9 Mn in 2023, growing at a CAGR of 31.2% during the forecast period from 2024 to 2033.Overview of the Generative AI in Pharma MarketGenerative AI in pharma revolutionizes drug dis.

AI in Drug Discovery Market Size, Industry Report by Business Opportunity, Global Trend, Future Grow

AI in Drug Discovery Market Size, Industry Report by Business Opportunity, Global Trend, Future Grow
pharmiweb.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmiweb.com Daily Mail and Mail on Sunday newspapers.

AI for Drug Discovery Market 2021 Expertise Research Emerging Trends, Top Market Leaders and Top to Bottom Analysis Till 2027 | Atomwise, Inc ,Insilico Medicine,BIOAGE,Numerate,NuMedii, Inc ,Envisagenics & More

AI for Drug Discovery Market 2021 Expertise Research Emerging Trends, Top Market Leaders and Top to Bottom Analysis Till 2027 | Atomwise, Inc ,Insilico Medicine,BIOAGE,Numerate,NuMedii, Inc ,Envisagenics & More
texasguardian.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from texasguardian.com Daily Mail and Mail on Sunday newspapers.

Global Artificial Intelligence (AI) in Drug Discovery Market At A CAGR Of 40 5% Growth, Trends And Absolute Opportunity Up To 2027||Atomwise, Inc , DEEP GENOMICS, Cloud Pharmaceuticals, Inc , Insilico Medicine, BenevolentAI   Ltd – KSU

Data Bridge Market Research analyses the market to account to USD 3,932.87 million by 2027 36 Artificial intelligence (AI) in drug discovery market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses the market to account to USD 3,932.87 million by 2027 growing at a CAGR of 40.5% in the above-mentioned forecast period. The growing awareness amongst the physicians and patients regarding the benefits of artificial intelligence has been directly impacting the growth of the market. The major players covered in the artificial intelligence (AI) in drug discovery market report are  Microsoft, NVIDIA Corporation, IBM Corporation, Atomwise, Inc., DEEP GENOMICS, Cloud Pharmaceuticals, Inc., Insilico Medicine, BenevolentAI   Ltd, Exscientia, Cyclica Inc., Numerate, NuMedii, Inc., Envisagenics., twoXAR, Incorporated, OWKIN, INC., XtalPi Inc., BERG LLC, among other domestic and global players.

Global Artificial Intelligence (AI) in Drug Discovery Market Study including Growth Factors, New Top Players, Competitive Analysis by regions from 2021 to 2027 – KSU

Data Bridge Market Research recently added “ Global Artificial Intelligence (AI) in Drug Discovery Market by manufacturers, regions, type and application, forecast to 2028” in his database. This research report focus on complete assessment of market and contains future trend, growth factors, attentive opinions, facts, historical data, statistically supported and industry-validated market data. Environmental concerns & regulatory guidelines regarding release of effluents through different industries. Global Artificial Intelligence (AI) in Drug Discovery Market comprehensive coverage of underlying economic and technological factors under key trend analysis. Global Artificial Intelligence (AI) in Drug Discovery Market By Offering (Software, Services),  Technology (Machine Learning, Other Technologies), Drug Type (Small Molecule, Large Molecules), Application (Immuno-Oncology, Neurodegenerative Diseases, Cardiovascular Disease, Metabolic Diseases, Other Applications), End-User

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.